Kyverna Therapeutics, Inc. (KYTX)
Nasdaq: KYTX · Biological Products, (No Diagnostic Substances) · Emeryville, CA · filing with the SEC since 2023
Who runs Kyverna Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Biddle Warner Weston
Chief Executive Officer. First filing Sep 2024, latest Mar 17, 2026, 0 filings in all.
Officers reporting now
8
of 14 people with a filing in the last fifteen months
Directors reporting now
6
21 people on the record since 2024
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Shaw Christi | Executive Chairperson | Sep 2024 | May 29, 2026 | none |
| Martini Gregory S. | Chief Financial Officer | May 2026 | May 20, 2026 | none |
| Dac Nadia | Chief Commercial Officer | May 2026 | May 6, 2026 | none |
| Biddle Warner Weston | Chief Executive Officer | Sep 2024 | Mar 17, 2026 | none |
| Grasso Marc | Chief Financial Officer | Jul 2025 | Mar 17, 2026 | none |
| Gehchan Naji | Exhibit 24 - Power of Attorney Chief Medical & Development Officer | Jan 2025 | Mar 17, 2026 | none |
| Pujols Mayobanex | Chief Technology Officer | Feb 2026 | Feb 11, 2026 | none |
| Walker Karen Marie | Chief Technology Officer | Feb 2024 | Dec 17, 2025 | 1 · $300,000 |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Aktar Mert | director | Oct 2024 | May 29, 2026 | none |
| Clark Ian T | director | Feb 2024 | May 29, 2026 | none |
| Cohen Fred E | director | Feb 2024 | May 29, 2026 | none |
| Seidenberg Beth C | director | Feb 2024 | May 29, 2026 | none |
| Miller Andrew Craig | director | Feb 2026 | Mar 4, 2026 | none |
| Emany Sravan Kumar | director | Feb 2026 | Feb 26, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Westlake Biopartners Fund I, L.P. | 10% owner | Feb 2024 | Dec 22, 2025 | none |
| Westlake Biopartners Gp I, LLC | 10% owner | Feb 2024 | Dec 22, 2025 | none |
| Westlake Biopartners Opportunity Fund I, L.P. | 10% owner | Feb 2024 | Dec 22, 2025 | none |
| Westlake Biopartners Opportunity Gp I, LLC | 10% owner | Feb 2024 | Dec 22, 2025 | none |
Earlier names on the record21, newest filing first
Spiegelman Daniel K · director · last filing Jun 2025Jones Ryan Alexander · officer · last filing Apr 2025Bain Capital Life Sciences Fund III, L.P. · 10% owner · last filing Feb 2024Bain Capital Life Sciences III General Partner, LLC · 10% owner · last filing Feb 2024Bain Capital Life Sciences Investors, LLC · 10% owner · last filing Feb 2024Bain Capital Life Sciences Opportunities III Gp, LLC · 10% owner · last filing Feb 2024Bain Capital Life Sciences Opportunities III, LP · 10% owner · last filing Feb 2024Harper Sean E · 10% owner · last filing Feb 2024Vida Ventures Gp III, L.L.C. · 10% owner · last filing Feb 2024Vida Ventures III-A, L.P. · 10% owner · last filing Feb 2024Vida Ventures III, L.P. · 10% owner · last filing Feb 2024Vida Ventures, LLC · 10% owner · last filing Feb 2024Gilead Sciences, Inc. · 10% owner · last filing Feb 2024Northpond Ventures III Gp, LLC · 10% owner · last filing Feb 2024Northpond Ventures III, LP · 10% owner · last filing Feb 2024Rubin Michael P. · 10% owner · last filing Feb 2024Liapis Stephen Constantine · director · last filing Feb 2024Maag Peter · officer · last filing Feb 2024Borie Dominique Christian · officer · last filing Feb 2024Chung James Bum · officer · last filing Feb 2024Kotzin Brian L. · director · last filing Feb 2024
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.